Expert Opinion on Drug Safety

Medication overuse headache
pp. 97-98(2)
Author: Haag, Gunther

The risks and the benefits of mesalazine as a treatment for ulcerative colitis
pp. 99-107(9)
Authors: Moss, Alan C; Peppercorn, Mark A

Immunological principles of T-cell-mediated adverse drug reactions in skin
pp. 109-124(16)
Authors: Naisbitt, Dean J; Pirmohamed, Munir; Park, B Kevin

Naloxone treatment in opioid addiction: the risks and benefits
pp. 125-132(8)
Authors: van Dorp, Eveline LA; Yassen, Ashraf; Dahan, Albert

Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin
pp. 133-145(13)
Authors: Sommer, Barbara R; Fenn, Howard H; Ketter, Terence A

Neuropsychiatric side effects of efavirenz therapy
pp. 147-154(8)
Authors: Arendt, Gabriele; de Nocker, Dominique; von Giesen, Hans-Juergen; Nolting, Thorsten

Tenofovir-induced kidney injury
pp. 155-164(10)
Authors: Gitman, Michael D; Hirschwerk, David; Baskin, Cindy H; Singhal, Pravin C

Aromatase inhibitors: a safety comparison
pp. 165-174(10)
Authors: Jonat, Walter; Hilpert, Felix; Kaufmann, Manfred

Incidence and management of cutaneous toxicities associated with cetuximab
pp. 175-182(8)
Authors: Saif, M Wasif; Kim, Richard

The safety profile of cyclophosphamide in multiple sclerosis therapy
pp. 183-190(8)
Authors: Perini, Paola; Calabrese, Massimiliano; Rinaldi, Luciano; Gallo, Paolo

Metformin before and during pregnancy and lactation in polycystic ovary syndrome
pp. 191-198(8)
Authors: Glueck, Charles J; Wang, Ping

Drug-induced splenic enlargement
pp. 199-206(8)
Author: Petroianu, Andy

Histologically defined biomarkers in toxicology
pp. 207-215(9)
Authors: Kilty, Cormac G; Keenan, Joe; Shaw, Martin

Optimizing the preclinical/clinical interface: an Informa Life Sciences conference
pp. 217-224(8)
Author: Cavero, Icilio